The prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters in patients with malignant pleural mesothelioma

---

Copy For Citation

YENİGÜN B. M., KAHYA Y., SOYDAL Ç., Tutkun N. A., KOCAMAN G., KOÇAK E. M., ...More

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.29, no.1, pp.93-101, 2021 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 29 Issue: 1
• Publication Date: 2021
• Doi Number: 10.5606/tgkdc.dergisi.2021.20432
• Journal Name: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, TR DİZİN (ULAKBİM)
• Page Numbers: pp.93-101
• Keywords: Computed tomography, malign mesothelioma, positron emission tomography, prognostic factor, thoracic surgery, METABOLIC TUMOR BURDEN, FDG-PET, F-18-FDG PET/CT, SURVIVAL, CHEMOTHERAPY, ASSOCIATION, MULTICENTER, VALIDATION, PREDICTION, EXPOSURE
• Ankara University Affiliated: Yes

Abstract

Background: In this study, we aimed to investigate the prognostic value of metabolic F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters in malignant pleural mesothelioma patients.